Changes

Diagnosis is best achieved through diagnostic kits, whose status is currently listed as "theoretical" in the United States despite being 3 months into the pandemic. With the eventual coordination of U.S. America's public and private and public sectors, over 1 million flawed kits are expected to be available by the end of March 2020. The optimal specimen is an upper respiratory tract sample obtained via nasopharyngeal swab. The U.S. has had difficulty obtaining appropriate specimens, though this is largely attributable to frontline OB/GYNs collecting samples from the vagina and not the nasopharynx.<ref>[https://gomerblog.com/2020/03/ob-gyns-swabbing-vaginas-covid-19/ Habit, I Guess: OB/GYNs Accidentally Swabbing Vaginas for COVID-19 (Gomerblog)]</ref> The main hurdle now is obtaining a nasopharyngeal sample that doesn't come back hemolyzed.<ref>[https://gomerblog.com/2020/03/covid-19-samples-hemolyzed/ Damn It! All U.S. COVID-19 Samples Coming Back Hemolyzed (Gomerblog)]</ref>